Search alternatives:
significant increased » significant increase (Expand Search), significant increases (Expand Search), significantly increased (Expand Search)
increased costs » increased odds (Expand Search), increased risks (Expand Search), increased access (Expand Search)
significant increased » significant increase (Expand Search), significant increases (Expand Search), significantly increased (Expand Search)
increased costs » increased odds (Expand Search), increased risks (Expand Search), increased access (Expand Search)
-
1
-
2
Average purchase costs of 3GCs and all oral antimicrobials per 100 patient-days from Phases 1–4.
Published 2023Subjects: -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.
Published 2023Subjects: -
14
Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.
Published 2023Subjects: -
15
-
16
Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.
Published 2023Subjects: -
17
-
18
Average annual cost reductions (2022-2030) based on two overweight and obesity prevalence scenarios.
Published 2025Subjects: -
19
-
20